Revisiting successful transplantation with marginal lungs: Fourteen years later, a new era of extended criteria

J Thorac Cardiovasc Surg. 2016 Dec;152(6):e135-e136. doi: 10.1016/j.jtcvs.2016.08.023. Epub 2016 Aug 29.

Authors

J Hunter Mehaffey¹, Robert B Hawkins², Eric J Charles², Curtis G Tribble²

Affiliations

¹ Division of Thoracic and Cardiovascular Surgery, Department of Surgery, University of Virginia, Charlottesville, Va. Electronic address: jhm9t@virginia.edu.
² Division of Thoracic and Cardiovascular Surgery, Department of Surgery, University of Virginia, Charlottesville, Va.

No abstract available

Publication types

Case Reports
Research Support, N.I.H., Extramural

MeSH terms

Cause of Death
Extracorporeal Membrane Oxygenation*
Fatal Outcome
Female
Humans
Immunosuppressive Agents / therapeutic use
Lung Transplantation*
Middle Aged
Pulmonary Fibrosis / surgery*
Respiratory Function Tests

Substances

Immunosuppressive Agents

Grants and funding

T32 HL007849/HL/NHLBI NIH HHS/United States